About Mark Smith
Form D filings for Bright Minds Biosciences in 2024 list Mark Smith as chief medical officer.
Mark Smith first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Smith in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Smith works with at each company, as listed on that company's latest Form D.
Bright Minds Biosciences Inc. · Form D, May 3, 2024
IM
Ian McDONALD
Chief Executive Officer and President, director
RC
Ryan Cheung
Chief Financial Officer
DW
David Weiner
Director
JF
Jeremy Fryzuk
Director
NB
Nils Bottler
Director
JP
Jan Pedersen
Chief Science Officer and director